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Abstract
Background: In earlier studies, pain assessment in pa-
tients with Alzheimer’s disease (AD) was conducted by
interview, for which reliability is questionable consid-
ering the decline in expressive and receptive language
abilities in AD. As similar language problems occur in
young children, the reliability of pain assessment in this
latter population is increased by employing visual ana-
logue scales. Objective: By employing visual analogue
scales, the current study investigated whether (1) nonde-
mented elderly persons and AD patients comprehend
the purpose of the scales and (2) AD patients, compared
to nondemented elderly persons, report suffering less
pain intensity and pain affect. Methods: Three visual
analogue scales, i.e. the Colored Analogue Scale (CAS),
the Faces Pain Scale (FPS), and the Facial Affective Scale
(FAS) were administered to patients in an early and mid-
stage of AD and to nondemented elderly persons. Re-
sults: The results show that the percentage of subjects
who comprehended the CAS, FAS and FPS was for the
nondemented elderly persons 100, 75 and 100%, respec-
tively, for the early AD group 100, 50 and 60%, respec-
tively, and for the midstage AD group 80, 20 and 30%,
respectively. Furthermore, elderly persons without de-
mentia reported experiencing more intense pain and
pain affect than the early and midstage AD group. Inter-
estingly, the early and midstage AD patients did not dif-
fer in reporting pain affect. Conclusion: Visual analogue
scales may improve pain assessment in those AD pa-
tients who fully comprehend the meaning of the scales.
As only the minority of midstage AD patients understood
the purpose of the FAS and FPS, the search for tools, par-
ticularly to assess pain affect in this population, must
continue.
Copyright © 2000 S. Karger AG, Basel
Introduction
Compared to elderly persons without dementia, pa-
tients with Alzheimer’s disease (AD) appear to use fewer
analgesics [1, 2]. The low use of analgesics in AD is often
explained by patients’ inability to communicate informa-
tion about their pain [3, 4]. This explanation would imply
that the progressive communicative deterioration in AD
will be reflected in a progressive decrease in use of analge-
sics. However, the findings of a recent study show that the
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use of analgesics appeared to be independent of the stage
of AD [5]. An alternative explanation is that, compared to
nondemented elderly persons, AD patients may have an
altered pain experience. Indeed, the hypothalamus, the
septohippocampal region, the amygdala, and the intra-
laminar nuclei of the thalamus which play a significant
role in the affective responses to pain [6, 7], are affected in
AD [8, 9].
An alteration in pain experience in AD is also support-
ed by clinical evidence. It has been observed that, com-
pared to nondemented elderly persons, elderly persons
with dementia suffered less from the postlumbar puncture
headache, an affective painful condition [10, 11]. In
another study, several pain questionnaires including
items on both pain intensity and pain affect were admin-
istered to AD patients and elderly persons without de-
mentia [Scherder and Bouma, unpubl. data]. The results
reveal that AD patients, compared to normal elderly per-
sons, report suffering less pain intensity and pain affect.
Some investigators observed that the administration of
pain questionnaires can take place in a reliable way in
mild and moderate cognitively impaired elderly persons
[12, 13]. However, it remains unclear whether AD pa-
tients were included in these studies. So far, in the few
studies concerning pain in AD patients [5; Scherder and
Bouma, unpubl. data], pain assessment took place
through the use of questionnaires which completely de-
pends on patients’ expressive and receptive language abil-
ities, functions which deteriorate during the course of AD
[14, 15]. Consequently, it is hard to exclude the possibility
that the patient misunderstood one or more items of the
questionnaire. Young children (!7 years) also have prob-
lems with expression and understanding language [16],
and the reliability of pain assessment in this population
has been found to increase by the administration of visual
analogue scales [16, 17]. Therefore, in the present study
three visual analogue scales, particularly developed for
young children, were administered to patients in an early
and midstage of AD and to elderly persons without
dementia. We examined whether (1) the subjects fully
comprehended the purpose of these scales and (2) com-
pared to elderly persons without dementia, AD patients
suffer from lower pain intensity and pain affect.
Methods
Subjects
The sample consisted of three groups: 20 AD patients (17
females, 3 males) in a relatively early stage, i.e. stage 5 of the Global
Deterioration Scale (GDS) [18]; 20 AD patients (16 females, 4 males)
in a midstage, i.e. stage 6 of the GDS, and 20 elderly persons without
dementia (17 female, 3 males). The three groups did not differ in age
(F(2,57) = 0.74, NS). The early AD patients had a mean age of 86.8
(range 75–95) the midstage AD patients had a mean age of 82.3
(range 76–92), and the mean age of the nondemented elderly persons
was 87.1 (range 76–96). Moreover, the early AD group, the midstage
AD group and the nondemented group were matched for education
(five categories: elementary school not finsihed: score = 1; elementary
school: score = 2; lower secondary school: score = 3; higher secondary
school: score = 4; higher vocational training for 18+/university:
score = 5): M = 2.8, M = 2.7 and M = 2.8, respectively.
All AD patients met the NINCDS-ADRDA criteria for the clini-
cal diagnosis of probable AD [19]. Subjects were excluded from par-
ticipation in this study if they had vision problems, a history of psy-
chiatric disorder, particularly depression, alcoholism, cerebral trau-
ma, cerebrovascular disease, hydrocephalus, neoplasm, epilepsy, dis-
turbances of consciousness, or focal brain disorders.
Level of cognitive functioning was assessed by using a shortened
12-item version [21] of the Mini-Mental State Examination (MMSE)
[20]. The 12-item MMSE version (maximum score 12) evaluates
orientation to time and place, registration, recall, attention, and cal-
culation, language and praxis, and visuoconstructive abilities [21].
Subjects with a score of !7, which is comparable to a score of !18 of
the 20-item MMSE version (maximum score 30) [21], were classified
as having serious cognitive disturbances. A score of !11, which is
comparable to a score of 24 of the 20-item MMSE version [21], indi-
cated mild cognitive deterioration. The mean score of the control
group, early stage and midstage AD group was 11.35 (range 11–12),
8.0 (range 7–10) and 3.70 (range 1–6), respectively.
Characteristics of Painful Conditions. The three groups also had
to be matched for chronic painful conditions, i.e. painful conditions
with a duration of at least 6 months. Separate conditions which might
cause pain for those with and without dementia were collected by one
of the authors (E.J.A.S.) by reviewing the medical records which were
kept by the former general practitioner and by the present nursing
home physician. These medical records included the subjects’ medi-
cal history and their present mental and physical status. Reports
from the neurologist, orthopedist, psychiatrist, and neuropsycholo-
gist were added as well. The following four categories of painful con-
ditions emerged, i.e. (1) arthritis/arthrosis; (2) recent fractures (with-
in the last year); (3) postoperative states (e.g. total hip) and (4) miscel-
laneous (tendinitis and diabetes neuropathia). These painful condi-
tions are similar to those generally observed in nursing home resi-
dents [22]. In the present study, subjects had either one or two pain-
ful conditions. The number of chronic painful conditions appeared
not to differ between the three groups (¯2 = 0.53, df = 2, NS). As for
the nature of the painful conditions, only fractures occurred signifi-
cantly more (¯2 = 6.09, df = 2, p ! 0.05) in the midstage AD patients
(40%), compared to the early stage AD patients (15%) and control
group (10%).
Comorbidity. The prevalence of specific categories of illness in
demented and nondemented subjects were compared to ascertain
whether the latter group have diseases which might contribute to
their pain experience. Specific categories of illness included conges-
tive heart failure, peripheral vascular disease, chronic pulmonary dis-
ease, diabetes mellitus, chronic renal failure, tumors, ulcer disease,
anemia, hyper/hypothyroidism, cholecystectomy, hearing and vision
problems, urology, hypertension, Dupuytren’s disease, migraine,
diverticulosis, esophagitis, liver disturbances, psoriasis, and Me-
nière’s disease. First, for each separate category of illness, compari-
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Fig. 1. The CAS to rate pain intensity. Left: front of the CAS as seen by the subjects; right: back of the CAS which
shows the numerical value of the rating shown on the CAS. Reprinted from McGrath et al. [17], with permission from
Elsevier Science.
Fig. 2. The ordered FAS to rate pain affect. Top: front of the FAS as seen by the subjects; bottom: back of the FAS
which shows the numerical values. Reprinted from McGrath et al. [17], with permission from Elsevier Science.
sons were made between the three groups employing ¯2 tests. Only
hypertension occurred with a significantly higher frequency in the
nondemented group (55%), compared to the early stage AD group
(20%) and the midstage AD group (15%) (¯2 = 9.05, df = 2, p ! 0.02),
a finding which has been reported in an earlier study [3]. Subsequent-
ly, the total number of illnesses between the three groups was com-
pared. The results reveal that the total number of illnesses differed
significantly between the control group (M = 2.80) and the midstage
AD group (M = 1.55) (Mann-Whitney U: Z = 3.24, p ! 0.002).
Materials and Procedure
Visual Analogue Scales
As the present study was meant to assess whether nonverbal mea-
sures could contribute to a reliable assessment of pain intensity and
pain affect, three visual analogue scales were administered. These
three scales minimize cognitive demands and are, therefore, particu-
larly suitable for adult populations with cognitive deterioration like
AD. The three scales were administered in the following order.
The Colored Analogue Scale (CAS) [17] (fig. 1): The CAS is
designed to assess the intensity of pain children are experiencing, in a
nonverbal manner. The different scale positions are marked by dif-
ferent colors and areas which facilitate the subject’s selection of a
scale position which best reflects his pain intensity [17]. Selecting the
appropriate scale position takes place by sliding a horizontal marker
from the bottom (no pain) to the top (maximum pain). The subject’s
score is the numerical value on the back of the scale which matches
the selected scale position.
The Facial Affective Scale (FAS) [17] (fig. 2): The FAS is primari-
ly aimed at assessing the affective components of pain [17]. The FAS
includes line drawings of nine faces, ranging in expression from very
happy (no pain) to very painful (most severe pain). As the original
faces are 2 cm high, they were enlarged up to 4 cm. On the back of the
faces, numerical values are printed, ranging from 0.04 (very happy:
no pain) to 0.97 (very painful: most severe pain). The numerical val-
ues for the FAS were calculated in an earlier study [23]. The subject’s
score is reflected in the numerical value on the back of the faces.
1 2
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Fig. 3. The FPS. Reprinted from Bieri et al. [16], with permission from Elsevier Science.
The Faces Pain Scale (FPS) [16] (fig. 3): The FPS primarily mea-
sures the severity of pain and possibly, to a lesser extent, its affective
components [16]. This scale can be reliably and validly administered
to children as young as 3 years of age [16]. The FPS consists of line
drawings of seven faces, i.e. one neutral face and six faces which
express increasing feelings of pain. Each face is 6 cm high. The faces
were rank-ordered from 0 to 6, from left to right. Subjects could rank
their feelings from ‘no pain’ (score 0, the neutral face, at the extreme
left side), to most severe pain (score 6, the face expressing most feel-
ings of pain, at the extreme right side). The subject’s score is identical
to the scale number, i.e. ranging from 0 to 6.
Administration of Scales. For each scale, subjects were first tested
for comprehension of the concept. For the FAS and FPS, they were
asked to indicate which face showed most pain and which face
showed least pain. For the CAS they were asked to indicate at what
level the marker should be positioned when a person had the most
severe pain (top of the scale) or no pain at all (bottom of the scale).
The were then asked to point on the FPS to the face which best
reflected the pain they currently experience, and on the FAS to
choose the face that matched his/her deep inner feelings and not just
the way they felt when in pain. On the CAS they were asked to indi-
cate where the marker should be to match their own pain level.
Data Analyses
The SPSS-PC program was used for statistical analyses, including
one- and two-tailed paired t-tests, ¯ 2 tests and Mann-Whitney U-tests
at a 0.05 significance level [24].
Results
For each separate scale, the data will be presented as
follows: (a) comprehension of the scale, i.e. the number of
subjects who did and did not comprehend the purpose of
the scale, and (b) report of pain experience. Only those
subjects who did unterstand the scale were included in the
analyses.
The Colored Analogue Scale (CAS)
Comprehension of the scale (table 1): The three groups
showed a significant difference in comprehending the
scale (¯2 = 8.57, df = 2, p ! 0.02). Interestingly, the 20
nondemented elderly persons and the 20 early AD pa-
tients understood perfectly well the meaning of the scale.
As even 16 out of 20 midstage AD patients also compre-
hended the purpose of the scale, only a trend was observed
between this group and both the nondemented and the
early AD group (Fisher’s exact: p ! 0.06).
Report of pain experience: The results show that the
intensity of pain is reported significantly differently by
the three groups (F(2,53) = 56.98, p ! 0.002). More specif-
ically, elderly persons without dementia experienced sig-
nificantly more intense pain when compared to early and
midstage AD patients (table 2). Furthermore, compared
to the early AD patients, midstage AD patients reported
experiencing the least intense pain (table 2).
The Facial Affective Scale (FAS)
Comprehension of the scale (table 1): In understanding
the proper meaning of the scale, the three groups showed a
significant difference (¯2 = 12.15, df = 2, p ! 0.003). It is
noteworthy that only 15 out of 20 nondemented elderly
persons could identify the correct minimal and/or maxi-
mum pain face. Although 10 early AD patients showed
correct identification, the difference between both groups
appeared not to be significant (¯2 = 2.67, df = 1, p ! 0.11).
However, comparison of the percentage of nondemented
elderly persons who identified the appropriate face with
the percentage of the midstage AD patients (20%) who
did, revealed a significant difference (¯2 = 12.13, df = 1,
p ! 0.001). The early and midstage AD groups also dif-
fered significantly (¯2 = 3.96, df = 1, p ! 0.05).
Report of pain experience: Experience of pain affect
varied significantly between the three groups (Kruskall-
Wallis: ¯2 = 18.70, df = 2, p ! 0.0001). As table 2 shows,
the nondemented elderly persons indicated suffering sig-
nificantly more pain affect than the early and midstage
AD group. However, no significant difference was found
between the early and midstage AD group.
Nondemented elderly persons (n = 20)
CAS
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Table 1. Percentage of nondemented
elderly persons, early AD patients and
midstage AD patients who fully
comprehended the purpose of the three
visual analogue scales
Comprehension of the scales
CAS
n %
FAS
n %
FPS
n %
20 100 15 75 20 100
Early AD (n = 20) 20 100 10 50 12 60
Midstage AD (n = 20) 16 80 4 20 6 30
Table 2. Means, number of subjects, and Mann-Whitney U tests of the three visual analogue scales concerning subjects’ actual pain experi-
ence
Controls
mean n
Early AD
mean n
Midstage AD
mean n
Mann-Whitney U-test
controls – early AD
Z p
controls – midstage AD
Z p
early stage – midstage AD
Z p
8.4 20 2.9 20 1.5 16 4.89 !0.0001 4.93 !0.0001 1.75 !0.05
FAS 86.33 15 51.67 9 38.67 3 3.96 !0.0001 2.71 !0.01 0.68 NS
FPS 4.90 20 1.91 11 0.80 5 4.21 !0.00001 3.55 !0.001 2.05 !0.05
Controls = Nondemented elderly persons; AD = Alzheimer’s disease.
The Faces Pain Scale (FPS)
Comprehension of the scale (table 1): The results show
that all 20 nondemented elderly persons, 12 out of 20 ear-
ly AD patients, and 6 out of 20 midstage AD patients
comprehended the scale. Hence, the three groups differed
significantly with respect to the percentage of subjects
who comprehended the scale (¯2 = 21.24, df = 2, p !
0.00001). More specifically, a significant difference was
observed between the 20 nondemented elderly persons
and the 12 early AD patients (Fisher’s exact: p ! 0.02),
and between the 20 nondemented elderly persons and the
6 midstage AD patients (Fisher’s exact: p ! 0.00001). The
difference between the early and midstage AD group who
comprehended the scale showed a trend (¯2 = 3.64, df = 1,
p ! 0.06).
Report of pain experience: Between the three groups, a
significant difference was observed with respect to the
extent to which subjects reported suffering pain (Kruskal-
Wallis: ¯2 = 24.68, df = 2, p ! 0.0001). Elderly persons
without dementia reported experiencing significantly
more pain than both early and midstage AD patients (ta-
ble 2). Early AD patients indicated perceiving significant-
ly more pain than midstage AD patients.
Discussion
Comprehension of the Various Scales
CAS: The results of the present study show that the
CAS was correctly interpreted by all elderly persons with-
out dementia and by early AD patients, and even by 80%
of the midstage AD patients.
FAS and FPS: The second best interpreted scale ap-
peared to be the FPS which was fully comprehended by all
nondemented elderly persons, and by 60 and 30% of the
early and midstage AD patients, respectively. In other
words, for all nondemented elderly persons and for the
majority of the early AD patients, the FPS might substan-
tially contribute to the assessment of both pain intensity
and pain affect. The least clear-cut scale seemed to be the
FAS, i.e. even 25% of the elderly persons without demen-
tia, and 50 and 80% of the early and midstage AD
patients, respectively, misinterpreted the scale. Interest-
ingly, 25% of the nondemented elderly persons and 50%
of the early AD patients failed to identify the smiling face
as the no-pain face. Specifically, this finding confirms the
concern of Bieri et al. [16] who replaced this face by a
neutral face.
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Recently in another study, a nonverbal observational
tool, i.e. the Checklist of Nonverbal Pain Indicators
(CNPI), also appeared to assess pain in a valid way in a
cognitively impaired sample [25]. As it is not clear which
groups of patients were included in that study [25], it
would be interesting to use the CNPI in a further study
with AD patients. Taken together, it is concluded that,
compared to the FPS and the FAS, the CAS works best for
both mildly and moderately demented patients. In addi-
tion, the CAS and the FPS could be used in nondemented
elderly persons.
Report of Pain Experience
As only a small number of midstage AD patients com-
prehended the FAS and the FPS, the conclusions about
these patients’ reports of pain experience relative to non-
demented elderly persons and early AD patients should
be considered with caution.
The results of the CAS and FPS show that, compared
to early and midstage AD patients, nondemented elderly
persons indicated that they experienced much more in-
tense pain. Furthermore, within the AD group, early AD
patients reported a higher pain intensity than midstage
AD patients. The results of the FAS suggest that, com-
pared to early and midstage AD patients, nondemented
elderly persons indicated that they suffered much more
from the affective components of pain. The decrease in
report of pain affect appeared to be similar in both AD
groups. It is important to note that the present study is
primarily concerned with the assessment of comprehensi-
bility of the scales and the evaluation of the scales by the
patients’ report of pain. However, the patients’ report of
pain should not be equated with their actual pain experi-
ence. The data of the present study do not provide evi-
dence that, compared to nondemented elderly persons,
AD patients perceived less discomfort due to neuropatho-
logical changes in affected brain areas. The only method
to really assess pain experience in AD would be to evalu-
ate the patients’ responses to experimental pain stimuli.
We suggest that such a study should be done in the
future.
Limitations
The present study has several limitations: (1) Although
the three groups were matched for chronic painful condi-
tions (only fractures occurred significantly more in the
midstage AD group, compared to the two other groups),
the question arises whether the painful conditions have an
identical impact on the subjects. For example, the severity
of the painful condition might vary between the subjects
of the three groups. (2) The total number of illnesses (co-
morbidity) was much higher in the control group than in
the midstage AD group. Although most of these illnesses
are not directly related to pain, they provide discomfort
which might indirectly influence pain experience. (3) The
scales were administered in the following order: CAS,
FAS, FPS. During the administration of the FAS the sub-
jects were confronted with faces whose affective meaning
they had to evaluate for the first time. It may be that the
results of the FPS were influenced by the fact that the
patients had already seen a similar set of faces in the FAS.
To avoid any bias in future, the FAS and FPS should not
be administered in succession. (4) Considering the pro-
gressive decline in memory in AD, only the patients’ pain
experience at the moment of administration of the scales
can be reliably assessed. A suggestion for future research
may be to diagnose AD patients’ pain experience (pain
intensity and pain affect) on a daily basis during a longer
period (e.g. 3 months). Daily pain assessment may mini-
mize the influence of memory disturbances on AD pa-
tients’ pain report.
Conclusion
In sum, visual analogue scales may improve pain
assessment in those AD patients who fully comprehend
the meaning of the scales. The finding that the CAS was
least understood in the midstage AD group and that the
FPS was less well understood in both early and midstage
AD patients emphasizes that when using both scales, the
clinician or nurse must first make sure that the patient
comprehends the concept. Finally, the present findings
show that the search for tools, especially to assess pain
affect in this population, must continue.
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